Aquestive Therapeutics Inc. (AQST)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 78
-0.28
-6.8966%
$
599.73M Market Cap
- P/E Ratio
- Div Yield
5.24M Volume
-0.09 Eps
$ 4.06
Previous Close Want to track AQST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aquestive Therapeutics Inc. (AQST) Statistics
Valuation metrics
Market Cap 599.73M
Enterprise value 560.24M
Trailing P/E (ttm) -7.35
Forward P/E -
PEG ratio -6.55
Price/Sales (ttm) 11.09
Price/Book (mrq) -10.56
Enterprise Value/Revenue 10.36
Enterprise Value/EBITDA -9.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.76M
Average volume (90 days) 1.91M
Price summary
52-Week low 2.93
52-Week high 7.55
Beta -
50-Day moving average 4.77
200-Day moving average 4.26
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.45%
Operating margin -0.98%
Operational effectiveness
Return on assets -0.59%
Return on equity 2.44%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.43
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.63
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.79
Total debt (mrq) -
Total Debt/Equity (mrq) -1.04
Current ratio (mrq) 7.19%
Book value per share (mrq) -0.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
